This inventor holds 6 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Agency for Science, Technology and Research. Active years: 2019-2024.
Company Filing History:
Years Active: 2019-2024
Title: Angeline Goh: Innovator in Antibody Research
Introduction
Angeline Goh is a prominent inventor based in Singapore, known for her significant contributions to the field of antibody research. With a total of 6 patents to her name, she has made remarkable strides in developing therapeutic applications that target critical health issues.
Latest Patents
Her latest patents include groundbreaking work on Anti-HER2 antibodies. This invention discloses antibodies, antigen-binding fragments, and polypeptides that bind to HER2, along with nucleic acids and vectors encoding these molecules. The patent also covers cells that comprise these antibodies and methods for their production, emphasizing their therapeutic applications. Another notable patent is focused on IL-1β neutralizing human monoclonal antibodies. This invention is directed towards antigen-binding proteins, providing compositions that include these proteins, their uses, and methods for production.
Career Highlights
Angeline Goh is affiliated with the Agency for Science, Technology and Research, where she continues to push the boundaries of scientific innovation. Her work has been instrumental in advancing the understanding and treatment of diseases through antibody technology.
Collaborations
She has collaborated with esteemed colleagues such as Cheng-I Wang and Subhra Kumar Biswas, contributing to a rich environment of research and innovation.
Conclusion
Angeline Goh's contributions to antibody research exemplify her dedication to advancing medical science. Her innovative patents and collaborative efforts continue to pave the way for future breakthroughs in therapeutic applications.